STOCK TITAN

[Form 4] QCR Holdings Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Laura L. Ekizian, President & CEO of QCR Holdings Inc (QCRH), reported an insider sale on 09/05/2025. She disposed of 333 shares of QCRH common stock at a price of $80 per share. After the transaction she directly owns 5,632 shares and indirectly beneficially owns 9,903 shares through a managed account. The Form 4 was signed on behalf of the reporting person by Shellee Showalter on 09/05/2025. The filing documents a routine Section 16 disclosure of a sale by a named executive without further commentary or additional transactions disclosed.

Laura L. Ekizian, Presidente e Amministratore Delegato di QCR Holdings Inc (QCRH), ha dichiarato una vendita di azioni da insider in data 09/05/2025. Ha ceduto 333 azioni ordinarie QCRH a $80 ciascuna. Dopo l'operazione detiene direttamente 5.632 azioni e possiede beneficiariamente in via indiretta 9.903 azioni tramite un conto gestito. Il Modulo 4 è stato firmato per conto della persona segnalante da Shellee Showalter in data 09/05/2025. La segnalazione documenta una divulgazione di routine ai sensi della Sezione 16 relativa a una vendita da parte di un dirigente nominato, senza commenti aggiuntivi o altre transazioni riportate.

Laura L. Ekizian, Presidenta y CEO de QCR Holdings Inc (QCRH), informó una venta como insider el 09/05/2025. Disposición de 333 acciones de acciones ordinarias de QCRH a un precio de $80 por acción. Tras la operación posee directamente 5.632 acciones y posee beneficiariamente de forma indirecta 9.903 acciones a través de una cuenta gestionada. El Formulario 4 fue firmado en nombre de la persona informante por Shellee Showalter el 09/05/2025. La presentación documenta una divulgación rutinaria conforme a la Sección 16 de una venta por parte de un ejecutivo nombrado, sin comentarios adicionales ni otras transacciones divulgadas.

Laura L. Ekizian, QCR Holdings Inc (QCRH)의 사장 겸 CEO는 2025-09-05에 내부자 매도를 보고했습니다. 그녀는 QCRH 보통주 333주를 주당 $80에 처분했습니다. 거래 후 그녀는 직접적으로 5,632주를 보유하고 있으며, 관리계정 통해 간접적으로 9,903주의 수익적 소유권을 보유하고 있습니다. Form 4는 보고인 대신 Shellee Showalter가 2025-09-05에 서명했습니다. 제출서는 지명 임원의 매도에 대한 섹션 16의 정기 보고를 기록하고 있으며, 추가 설명이나 다른 거래는 기재되어 있지 않습니다.

Laura L. Ekizian, présidente et PDG de QCR Holdings Inc (QCRH), a déclaré une cession d'initié le 05/09/2025. Elle a cédé 333 actions ordinaires QCRH au prix de 80 $ par action. Après la transaction, elle détient directement 5 632 actions et détient indirectement à titre bénéficiaire 9 903 actions via un compte géré. Le formulaire 4 a été signé pour la personne déclarant par Shellee Showalter le 05/09/2025. Le dépôt consigne une divulgation de routine au titre de la Section 16 concernant une vente par un dirigeant nommé, sans commentaires ni transactions supplémentaires divulgués.

Laura L. Ekizian, Präsidentin und CEO von QCR Holdings Inc (QCRH), meldete einen Insider-Verkauf am 09.05.2025. Sie veräußerte 333 Aktien der QCRH-Stammaktien zu einem Preis von $80 je Aktie. Nach der Transaktion besitzt sie unmittelbar 5.632 Aktien und hält mittelbar begünstigt 9.903 Aktien über ein verwaltetes Konto. Das Formular 4 wurde im Namen der meldenden Person von Shellee Showalter am 09.05.2025 unterzeichnet. Die Einreichung dokumentiert eine routinemäßige Offenlegung nach Abschnitt 16 über einen Verkauf durch eine namentlich genannte Führungskraft, ohne weitere Anmerkungen oder zusätzliche Transaktionen.

Positive
  • Timely disclosure of insider transaction through a filed Form 4
  • Clear ownership reporting showing both direct (5,632) and indirect (9,903) holdings
Negative
  • Insider sale of 333 shares at $80 which may be noted by investors monitoring insider activity

Insights

TL;DR CEO sold a small number of shares; disclosure is timely and routine.

The sale of 333 shares at $80 represents a modest disposition relative to total insider holdings disclosed on the form (5,632 direct, 9,903 indirect). There is no other transaction or derivative activity reported, and the Form 4 provides standard Section 16 transparency. From a market-impact perspective, this trade alone is unlikely to materially affect QCRH valuation given the size disclosed; however, investors often note insider sales as one data point for sentiment.

TL;DR Filing meets disclosure requirements; sale appears administrative rather than strategic.

The Form 4 shows proper reporting by an insider and includes both direct and indirect beneficial ownership amounts. The report does not indicate a Rule 10b5-1 plan or other explanatory text, and there is no evidence of unusual timing or large-scale liquidation. For governance assessment, the true significance depends on total outstanding insider holdings and company context, which are not provided in this filing.

Laura L. Ekizian, Presidente e Amministratore Delegato di QCR Holdings Inc (QCRH), ha dichiarato una vendita di azioni da insider in data 09/05/2025. Ha ceduto 333 azioni ordinarie QCRH a $80 ciascuna. Dopo l'operazione detiene direttamente 5.632 azioni e possiede beneficiariamente in via indiretta 9.903 azioni tramite un conto gestito. Il Modulo 4 è stato firmato per conto della persona segnalante da Shellee Showalter in data 09/05/2025. La segnalazione documenta una divulgazione di routine ai sensi della Sezione 16 relativa a una vendita da parte di un dirigente nominato, senza commenti aggiuntivi o altre transazioni riportate.

Laura L. Ekizian, Presidenta y CEO de QCR Holdings Inc (QCRH), informó una venta como insider el 09/05/2025. Disposición de 333 acciones de acciones ordinarias de QCRH a un precio de $80 por acción. Tras la operación posee directamente 5.632 acciones y posee beneficiariamente de forma indirecta 9.903 acciones a través de una cuenta gestionada. El Formulario 4 fue firmado en nombre de la persona informante por Shellee Showalter el 09/05/2025. La presentación documenta una divulgación rutinaria conforme a la Sección 16 de una venta por parte de un ejecutivo nombrado, sin comentarios adicionales ni otras transacciones divulgadas.

Laura L. Ekizian, QCR Holdings Inc (QCRH)의 사장 겸 CEO는 2025-09-05에 내부자 매도를 보고했습니다. 그녀는 QCRH 보통주 333주를 주당 $80에 처분했습니다. 거래 후 그녀는 직접적으로 5,632주를 보유하고 있으며, 관리계정 통해 간접적으로 9,903주의 수익적 소유권을 보유하고 있습니다. Form 4는 보고인 대신 Shellee Showalter가 2025-09-05에 서명했습니다. 제출서는 지명 임원의 매도에 대한 섹션 16의 정기 보고를 기록하고 있으며, 추가 설명이나 다른 거래는 기재되어 있지 않습니다.

Laura L. Ekizian, présidente et PDG de QCR Holdings Inc (QCRH), a déclaré une cession d'initié le 05/09/2025. Elle a cédé 333 actions ordinaires QCRH au prix de 80 $ par action. Après la transaction, elle détient directement 5 632 actions et détient indirectement à titre bénéficiaire 9 903 actions via un compte géré. Le formulaire 4 a été signé pour la personne déclarant par Shellee Showalter le 05/09/2025. Le dépôt consigne une divulgation de routine au titre de la Section 16 concernant une vente par un dirigeant nommé, sans commentaires ni transactions supplémentaires divulgués.

Laura L. Ekizian, Präsidentin und CEO von QCR Holdings Inc (QCRH), meldete einen Insider-Verkauf am 09.05.2025. Sie veräußerte 333 Aktien der QCRH-Stammaktien zu einem Preis von $80 je Aktie. Nach der Transaktion besitzt sie unmittelbar 5.632 Aktien und hält mittelbar begünstigt 9.903 Aktien über ein verwaltetes Konto. Das Formular 4 wurde im Namen der meldenden Person von Shellee Showalter am 09.05.2025 unterzeichnet. Die Einreichung dokumentiert eine routinemäßige Offenlegung nach Abschnitt 16 über einen Verkauf durch eine namentlich genannte Führungskraft, ohne weitere Anmerkungen oder zusätzliche Transaktionen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ekizian Laura L

(Last) (First) (Middle)
3551 SEVENTH STREET
SUITE 204

(Street)
MOLINE IL 61265

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
QCR HOLDINGS INC [ QCRH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO, QCBT
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 S 333 D $80 5,632 D
Common Stock 9,903 I by Managed Account
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
By: Shellee Showalter For: Laura Ekizian 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Laura Ekizian report on Form 4 for QCRH?

She reported a sale of 333 shares of QCR Holdings common stock on 09/05/2025 at a price of $80 per share.

How many QCRH shares does the reporting person own after the transaction?

After the reported sale, the filing shows 5,632 shares directly and 9,903 shares indirectly via a managed account.

Does the Form 4 indicate the sale was part of a 10b5-1 plan?

No. The Form 4 does not include any statement indicating the transaction was made pursuant to a Rule 10b5-1 plan.

Who signed the Form 4 on behalf of the reporting person?

The Form 4 was signed by Shellee Showalter for Laura Ekizian on 09/05/2025.
Qcr Holdings

NASDAQ:QCRH

QCRH Rankings

QCRH Latest News

QCRH Latest SEC Filings

QCRH Stock Data

1.34B
16.34M
3.54%
77.04%
1.39%
Banks - Regional
State Commercial Banks
Link
United States
MOLINE